{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AST, Aspartate Transaminase", "ED, Effective Dose", "HED, Human Equivalent Dose", "Hepatotoxicity", "Herbal formulation", "INR, International Normalized Ratio", "Livogrit", "MELD, Model for end-stage liver disease", "TAA, Thioacetamide", "Thioacetamide", "Zebrafish"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35571233", "DateRevised": {"Year": "2023", "Month": "09", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.1016/j.toxrep.2022.03.053"], "Journal": {"ISSN": "2214-7500", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2022"}}, "Title": "Toxicology reports", "ISOAbbreviation": "Toxicol Rep"}, "ArticleTitle": "Livogrit, a herbal formulation of <i>Boerhavia diffusa</i>, <i>Phyllanthus niruri</i> and <i>Solanum nigrum</i> reverses the thioacetamide induced hepatocellular toxicity in zebrafish model.", "Pagination": {"StartPage": "1056", "EndPage": "1064", "MedlinePgn": "1056-1064"}, "Abstract": {"AbstractText": ["Research studies in the past years have shown encouraging therapeutic potential of herbal medicines in liver ailments. Livogrit is a well characterized formulation prepared by mixing extracts of plants, <i>Boerhavia diffusa</i>, <i>Phyllanthus niruri</i> and <i>Solanum nigrum</i> in precise ratios. Our study demonstrates the curative role of Livogrit in thioacetamide (TAA) induced zebrafish model of hepatotoxicity. This is a systematic study, wherein we first screened Livogrit for an effective dose and treatment time-course. Once established, we conducted subsequent experiments to compare the hepatoprotective effects of Livogrit with a reference drug, prednisone. We evaluated a wide range of liver function variables including, albumin, AST, bilirubin, creatinine, platelet clotting factor, INR and sodium blood serum to assess the degree of liver dysfunctionality. Results from screening experiments suggested that Livogrit treatment for 14 days at an effective dose (ED3-142 \u03bcg/kg) significantly revamped the deviated serum biochemistry. The experiments comparing prednisone and Livogrit demonstrated that the treatment with the herbal formation was more effective against TAA-induced hepatotoxicity. Liver function parameters indicating hepatic dysfunctionality showed better recovery with Livogrit as compared to prednisone. Furthermore, we enumerated a scoring method for assessing degree of liver dysfunctionality based on the values of bilirubin, creatinine and INR. The herbal formulation in comparison to prednisone successfully restored the liver dysfunction index to low risk. The liver cytology showed a decline in the hepatocyte cell death that further corroborated the promising curative potential of Livogrit."], "CopyrightInformation": "\u00a9 2022 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249405, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar 249405, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Patanjali Yog Peeth (UK) Trust, 40 Lambhill Street, Kinning Park, Glasgow G41 1AU, UK."}], "LastName": "Balkrishna", "ForeName": "Acharya", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249405, Uttarakhand, India."}], "LastName": "Lochab", "ForeName": "Savita", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249405, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar 249405, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India."}], "LastName": "Varshney", "ForeName": "Anurag", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Toxicol Rep", "NlmUniqueID": "101630272", "ISSNLinking": "2214-7500"}, "CoiStatement": "The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The test article was sourced from Divya Pharmacy, Haridwar, Uttarakhand, India. In addition to Patanjali Research Foundation Trust and University of Patanjali, AB holds an honorary managerial position in Divya Pharmacy Haridwar, India. Besides, providing the test article, Divya Pharmacy was, not involved in any aspect of this study. Divya Pharmacy, Haridwar India, manufactures and sells many herbal medicinal products, including Livogrit. SL and AV are employed at Patanjali Research Institute which is governed by Patanjali Research Foundation Trust (PRFT), Haridwar, Uttarakhand, India, a not\u00a0for-profit organization. In addition, AV is an adjunct professor in Department of Allied and Applied, Sciences, University of Patanjali, NH-58, Haridwar-249405, Uttarakhand, India; and in the Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi-110067, India. All other authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Trefts E., Gannon M., Wasserman D.H. The liver. Curr. Biol. 2017;27(21):R1147\u2013R1151. doi: 10.1016/j.cub.2017.09.019.", "ArticleIdList": ["10.1016/j.cub.2017.09.019", "PMC5897118", "29112863"]}, {"Citation": "Asrani S.K., Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world. J. Hepatol. 2019;70(1):151\u2013171. doi: 10.1016/j.jhep.2018.09.014.", "ArticleIdList": ["10.1016/j.jhep.2018.09.014", "30266282"]}, {"Citation": "Tsochatzis E.A., Bosch J., Burroughs A.K. Liver cirrhosis. Lancet. 2014;383(9930):1749\u20131761. doi: 10.1016/S0140-6736(14)60121-5.", "ArticleIdList": ["10.1016/S0140-6736(14)60121-5", "24480518"]}, {"Citation": "Ramos-Lopez O. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J. Gastroenterol. 2015;21(41):11552. doi: 10.3748/wjg.v21.i41.11552.", "ArticleIdList": ["10.3748/wjg.v21.i41.11552", "PMC4631960", "26556986"]}, {"Citation": "Rawat D., Shrivastava S., Naik R.A., Chhonker S.K., Mehrotra A., Koiri R.K. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma. Anticancer Agents Med. Chem. 2019;18(13):1838\u20131859. doi: 10.2174/1871520618666180604085612.", "ArticleIdList": ["10.2174/1871520618666180604085612", "29866017"]}, {"Citation": "Ghosh N., Ghosh R., Mandal V., Mandal S.C. Recent advances in herbal medicine for treatment of liver diseases. Pharm. Biol. 2011;49(9):970\u2013988. doi: 10.3109/13880209.2011.558515.", "ArticleIdList": ["10.3109/13880209.2011.558515", "21595500"]}, {"Citation": "Balkrishna A., Gohel V., Singh R., Bhattacharya K., Varshney A. Livogrit ameliorates acetaldehyde-induced steatosis in HepG2 cells through modulation of lipogenesis and \u03b2-oxidation pathways. Phytomedicine Plus. 2021;1(3) doi: 10.1016/j.phyplu.2021.100067.", "ArticleIdList": ["10.1016/j.phyplu.2021.100067"]}, {"Citation": "Balkrishna A., Sakat S.S., Ranjan R., et al. Polyherbal medicine divya sarva-kalp-kwath ameliorates persistent carbon tetrachloride induced biochemical and pathological liver impairments in wistar rats and in HepG2 cells. Front. Pharmacol. 2020;11:288. doi: 10.3389/fphar.2020.00288.", "ArticleIdList": ["10.3389/fphar.2020.00288", "PMC7109321", "32269524"]}, {"Citation": "Balkrishna A., Gohel V., Singh R., et al. Tri-herbal medicine divya sarva-kalp-kwath (Livogrit) regulates fatty acid-induced steatosis in human HepG2 cells through inhibition of intracellular triglycerides and extracellular glycerol levels. Molecules. 2020;25(20):4849. doi: 10.3390/molecules25204849.", "ArticleIdList": ["10.3390/molecules25204849", "PMC7587968", "33096687"]}, {"Citation": "Goessling W., Sadler K.C. Zebrafish: an important tool for liver disease research. Gastroenterology. 2015;149(6):1361\u20131377. doi: 10.1053/j.gastro.2015.08.034.", "ArticleIdList": ["10.1053/j.gastro.2015.08.034", "PMC4762709", "26319012"]}, {"Citation": "Rekha R.D., Amali A.A., Her G.M., et al. Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology. 2008;243(1-2):11\u201322. doi: 10.1016/j.tox.2007.09.007.", "ArticleIdList": ["10.1016/j.tox.2007.09.007", "17997003"]}, {"Citation": "Mohi-ud-din R., Mir R.H., Sawhney G., Dar M.A., Bhat Z.A. Possible pathways of hepatotoxicity caused by chemical agents. Curr. Drug Metab. 2019;20(11):867\u2013879. doi: 10.2174/1389200220666191105121653.", "ArticleIdList": ["10.2174/1389200220666191105121653", "31702487"]}, {"Citation": "Agrawal S., Dhiman R.K., Limdi J.K. Evaluation of abnormal liver function tests. Postgrad. Med. J. 2016;92(1086):223\u2013234. doi: 10.1136/postgradmedj-2015-133715.", "ArticleIdList": ["10.1136/postgradmedj-2015-133715", "26842972"]}, {"Citation": "Balkrishna A., Verma S., Solleti S.K., Khandrika L., Varshney A. Calcio-herbal medicine divya-swasari-vati ameliorates SARS-CoV-2 spike protein-induced pathological features and inflammation in humanized zebrafish model by moderating IL-6 and TNF-\u03b1 cytokines. J. Inflamm. Res. 2020;13:1219\u20131243. doi: 10.2147/JIR.S286199.", "ArticleIdList": ["10.2147/JIR.S286199", "PMC7783203", "33414643"]}, {"Citation": "Schalm S.W., Summerskill W.H., Go V.L. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone. Gastroenterology. 1977;72(5 Pt 1):910\u2013913. \u2329http://www.ncbi.nlm.nih.gov/pubmed/849821\u232a", "ArticleIdList": ["849821"]}, {"Citation": "Ducharme N.A., Reif D.M., Gustafsson J.-A., Bondesson M. Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing. Reprod. Toxicol. 2015;55:3\u201310. doi: 10.1016/j.reprotox.2014.09.005.", "ArticleIdList": ["10.1016/j.reprotox.2014.09.005", "PMC5396953", "25261610"]}, {"Citation": "Wallace C.K., Bright L.A., Marx J.O., Andersen R.P., Mullins M.C., Carty A.J. Effectiveness of rapid cooling as a method of euthanasia for young zebrafish (Danio rerio) J. Am. Assoc. Lab. Anim. Sci. 2018;57(1):58\u201363. \u2329http://www.ncbi.nlm.nih.gov/pubmed/29402353\u232a", "ArticleIdList": ["PMC5875099", "29402353"]}, {"Citation": "Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD) Hepatology. 2007;45(3):797\u2013805. doi: 10.1002/hep.21563.", "ArticleIdList": ["10.1002/hep.21563", "17326206"]}, {"Citation": "Kane A.B., Young E.E., Schanne F.A., Farber J.L. Calcium dependence of phalloidin-induced liver cell death. Proc. Natl. Acad. Sci. 1980;77(2):1177\u20131180. doi: 10.1073/pnas.77.2.1177.", "ArticleIdList": ["10.1073/pnas.77.2.1177", "PMC348448", "6767245"]}, {"Citation": "Gosselin R.-D. Guidelines on statistics for researchers using laboratory animals: the essentials. Lab. Anim. 2019;53(1):28\u201342. doi: 10.1177/0023677218783223.", "ArticleIdList": ["10.1177/0023677218783223", "29954248"]}, {"Citation": "Carvalho J.R., Machado M.V. New insights about albumin and liver disease. Ann. Hepatol. 2018;17(4):547\u2013560. doi: 10.5604/01.3001.0012.0916.", "ArticleIdList": ["10.5604/01.3001.0012.0916", "29893696"]}, {"Citation": "Hankey A. Ayurveda and the battle against chronic disease: an opportunity for Ayurveda to go mainstream? J. Ayurveda Integr. Med. 2010;1(1):9. doi: 10.4103/0975-9476.59819.", "ArticleIdList": ["10.4103/0975-9476.59819", "PMC3149400", "21829293"]}, {"Citation": "Dhiman R.K., Chawla Y.K. Herbal medicines for liver diseases. Dig. Dis. Sci. 2005;50(10):1807\u20131812. doi: 10.1007/s10620-005-2942-9.", "ArticleIdList": ["10.1007/s10620-005-2942-9", "16187178"]}, {"Citation": "Limdi J.K. Evaluation of abnormal liver function tests. Postgrad. Med. J. 2003;79(932):307\u2013312. doi: 10.1136/pmj.79.932.307.", "ArticleIdList": ["10.1136/pmj.79.932.307", "PMC1742736", "12840117"]}, {"Citation": "Child C.G., Turcotte J.G. Surgery and portal hypertension. Major Probl. Clin. Surg. 1964;1:1\u201385. \u2329https://pubmed.ncbi.nlm.nih.gov/4950264/\u232a", "ArticleIdList": ["4950264"]}, {"Citation": "Castello L., Pirisi M., Sainaghi P.P., Bartoli E. Hyponatremia in liver cirrhosis: pathophysiological principles of management. Dig. Liver Dis. 2005;37(2):73\u201381. doi: 10.1016/j.dld.2004.09.012.", "ArticleIdList": ["10.1016/j.dld.2004.09.012", "15733516"]}, {"Citation": "Godfrey E.L., Kueht M.L., Rana A., Awad S. MELD-Na (the new MELD) and peri-operative outcomes in emergency surgery. Am. J. Surg. 2018;216(3):407\u2013413. doi: 10.1016/j.amjsurg.2018.04.017.", "ArticleIdList": ["10.1016/j.amjsurg.2018.04.017", "29871737"]}, {"Citation": "Fragaki M. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann. Gastroenterol. Published online. 2019 doi: 10.20524/aog.2019.0417.", "ArticleIdList": ["10.20524/aog.2019.0417", "PMC6826070", "31700241"]}, {"Citation": "Wan S.-Z., Nie Y., Zhang Y., Liu C., Zhu X. Assessing the prognostic performance of the child-pugh, model for end-stage liver disease, and albumin-bilirubin scores in patients with decompensated cirrhosis: a large asian cohort from gastroenterology department. Dis. Markers. 2020;2020:1\u20139. doi: 10.1155/2020/5193028.", "ArticleIdList": ["10.1155/2020/5193028", "PMC7048909", "32148566"]}, {"Citation": "Dey D., Chaskar S., Bhatt N., Chitre D. Hepatoprotective activity of BV-7310, a proprietary herbal formulation of phyllanthus niruri, tephrosia purpurea, boerhavia diffusa, and andrographis paniculata, in alcohol-induced HepG2 cells and alcohol plus a haloalkane, CCl 4, induced liver damage. Evidence-Based Complement. Altern. Med. 2020;2020:1\u20139. doi: 10.1155/2020/6428906.", "ArticleIdList": ["10.1155/2020/6428906", "PMC7132358", "32308713"]}, {"Citation": "Hsieh C.-C., Fang H.-L., Lina W.-C. Inhibitory effect of Solanum nigrum on thioacetamide-induced liver fibrosis in mice. J. Ethnopharmacol. 2008;119(1):117\u2013121. doi: 10.1016/j.jep.2008.06.002.", "ArticleIdList": ["10.1016/j.jep.2008.06.002", "18606216"]}, {"Citation": "Tai C.-J., Choong C.-Y., Shi Y.-C., et al. Solanum nigrum protects against hepatic fibrosis via suppression of hyperglycemia in high-fat/ethanol diet-induced rats. Molecules. 2016;21(3):269. doi: 10.3390/molecules21030269.", "ArticleIdList": ["10.3390/molecules21030269", "PMC6274119", "26927042"]}, {"Citation": "Al Zarzour R., Ahmad M., Asmawi M., et al. Phyllanthus niruri standardized extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in Sprague\u2013Dawley rats. Nutrients. 2017;9(7):766. doi: 10.3390/nu9070766.", "ArticleIdList": ["10.3390/nu9070766", "PMC5537880", "28718838"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "5"}, {"Year": "2021", "Month": "12", "Day": "16"}, {"Year": "2022", "Month": "3", "Day": "30"}, {"Year": "2022", "Month": "5", "Day": "16", "Hour": "3", "Minute": "56"}, {"Year": "2022", "Month": "5", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35571233", "PMC9097504", "10.1016/j.toxrep.2022.03.053", "S2214-7500(22)00082-8"]}}], "PubmedBookArticle": []}